With evidence of significant variation among consent procedures in the NIPT space, and the potential for a lack of awareness about incidental findings, Bianchi recommends the field come together to standardize procedures and education.
In addition to offering NIPTs, Natera is eyeing the cancer diagnostics space.
The UK firm is using MALDI-TOF mass spec technology to develop the test as a screening tool for the disorder as early as eight weeks into a pregnancy.
The company said that the financing will go toward sales and marketing, as well as R&D on its Panorama NIPT, diagnostic tests for cancer, and clinical trials.
Three new studies, published online in the New England Journal of Medicine, shed light on how NIPT may be best integrated into clinical care for all pregnant women.
The partners will work to establish Centrum Badan as the preferred testing partner for the NGS-based test in Poland, which had 376,000 live births last year.
The NextSeq CN500 sequencer was developed in collaboration with Illumina to offer clinical non-invasive prenatal testing for the Chinese market.
The method improves a research tool that can view chromosome movement throughout the living cell nucleus in space and time, and has both research and clinical uses.
Under the three-year project award, Premaitha and St George's plan to establish a UK Centre of Excellence for Prenatal Screening.
Vendors and clinicians are struggling with how to deal with the growing number of cases of secondary findings from molecular non-invasive prenatal tests.
23andMe is offering early customers re-testing on newer chips for a fee, Wired reports.
He Jiankui is no longer affiliated with Direct Genomics Biotechnology, the single molecule sequencing company he founded, Nikkei Asian Review reports.
Newsweek writes about the hopes for precision medicine in cancer, but also challenges getting it to patients.
In Genome Research this week: genomic architecture of glioblastoma, predictive computational approach to estimate SNP fitness, and more.